San Diego startup says $25k can predict future health risks: 5 things to know

Visitors of the San Diego-based lab Health Nucleus are paying to learn their risks of developing cancer, cardiovascular, neurodegenerative and metabolic diseases, according to a CNBC report.

Here are five things to know.

1. Health Nucleus is the clinical research arm of Human Longevity, a San Diego-based startup that provides commercial gene sequencing services.

2. Human Longevity is collecting tens of millions of genomes, according to geneticist J. Craig Venter, PhD, company co-founder and executive chairman. He added Human Longevity analyzes genomes with machine learning to provide patients with actionable insights into future treatments or lifestyle changes.

3. Patients pay between $4,900 and $25,000 to undergo a day-long assessment that includes cognitive testing, an electrocardiogram and an MRI.

4. About 40 percent of people screened at Health Nucleus have found a serious health problem, Dr. Venter told CNBC.

5. Nearly 2.5 percent "have a major tumor that they don't know about," beginning as early as stage zero, Dr. Venter reported to CNBC.

More articles on health IT:

IBM brings 'new collar' IT training to US community colleges

House committee hosts hearing on healthcare cybersecurity

Social Security Administration taps IRS exec for CIO

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Articles We Think You'll Like

 

Featured Whitepapers

Featured Webinars